AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
ISOFORM-SPECIFIC VASOCONSTRICTION INDUCED BY APOLIPOPROTEIN-E AND MODULATION OF THIS EFFECT BY ALZHEIMERS BETA-AMYLOID PEPTIDE
Authors: PARIS D TOWN T PARKER TA HUMPHREY J MULLAN M
Citation: D. Paris et al., ISOFORM-SPECIFIC VASOCONSTRICTION INDUCED BY APOLIPOPROTEIN-E AND MODULATION OF THIS EFFECT BY ALZHEIMERS BETA-AMYLOID PEPTIDE, Neuroscience letters, 256(2), 1998, pp. 73-76
THE -491A T APOLIPOPROTEIN-E PROMOTER POLYMORPHISM ASSOCIATION WITH ALZHEIMERS-DISEASE - INDEPENDENT RISK AND LINKAGE DISEQUILIBRIUM WITH THE KNOWN APOE POLYMORPHISM/
Authors: TOWN T PARIS D FALLIN D DUARA R BARKER W GOLD M CRAWFORD F MULLAN M
Citation: T. Town et al., THE -491A T APOLIPOPROTEIN-E PROMOTER POLYMORPHISM ASSOCIATION WITH ALZHEIMERS-DISEASE - INDEPENDENT RISK AND LINKAGE DISEQUILIBRIUM WITH THE KNOWN APOE POLYMORPHISM/, Neuroscience letters, 252(2), 1998, pp. 95-98
THE BUTYRYLCHOLINESTERASE GENE IS NEITHER INDEPENDENTLY NOR SYNERGISTICALLY ASSOCIATED WITH LATE-ONSET AD IN CLINIC-BASED AND COMMUNITY-BASED POPULATIONS
Authors: CRAWFORD F FALLIN D SUO Z ABDULLAH L GOLD M GAUNTLETT A DUARA R MULLAN M
Citation: F. Crawford et al., THE BUTYRYLCHOLINESTERASE GENE IS NEITHER INDEPENDENTLY NOR SYNERGISTICALLY ASSOCIATED WITH LATE-ONSET AD IN CLINIC-BASED AND COMMUNITY-BASED POPULATIONS, Neuroscience letters, 249(2-3), 1998, pp. 115-118
THE APOE-EPSILON-4 ALLELE AND ALZHEIMER-DISEASE AMONG AFRICAN-AMERICANS, HISPANICS, AND WHITES
Authors: BARKER W HARWOOD D DUARA R MULLAN M FALLIN D HYSLOP PSG ROGAEVA E SONG YQ
Citation: W. Barker et al., THE APOE-EPSILON-4 ALLELE AND ALZHEIMER-DISEASE AMONG AFRICAN-AMERICANS, HISPANICS, AND WHITES, JAMA, the journal of the American Medical Association, 280(19), 1998, pp. 1661-1662
VASOACTIVITY OF BETA-AMYLOID PEPTIDE - BLOCKAGE BY PROPENTOFYLLINE
Authors: CRAWFORD F SUO Z FANG C PARKER T GOLD M MULLAN M
Citation: F. Crawford et al., VASOACTIVITY OF BETA-AMYLOID PEPTIDE - BLOCKAGE BY PROPENTOFYLLINE, Neurology, 50(4), 1998, pp. 2016-2016
ADDITIVE EFFECTS OF RISK-FACTORS FOR ALZHEIMERS-DISEASE (AD) IN WOMEN
Authors: BARKER W HARWOOD D BRAVO M AGUERO H GREENFIELD L HURWITZ D BUCHILLON D STGEORGEHYSLOP P MULLAN M DUARA R
Citation: W. Barker et al., ADDITIVE EFFECTS OF RISK-FACTORS FOR ALZHEIMERS-DISEASE (AD) IN WOMEN, Neurology, 50(4), 1998, pp. 4105-4105
ALZHEIMERS BETA-AMYLOID VASOACTIVITY - IDENTIFICATION OF A NOVEL BETA-AMYLOID CONFORMATIONAL INTERMEDIATE
Authors: CRAWFORD F SOTO C SUO ZM FANG CH PARKER T SAWAR A FRANGIONE B MULLAN M
Citation: F. Crawford et al., ALZHEIMERS BETA-AMYLOID VASOACTIVITY - IDENTIFICATION OF A NOVEL BETA-AMYLOID CONFORMATIONAL INTERMEDIATE, FEBS letters, 436(3), 1998, pp. 445-448
ROLE OF PEROXYNITRITE IN THE VASOACTIVE AND CYTOTOXIC EFFECTS OF ALZHEIMERS BETA-AMYLOID(1-40) PEPTIDE
Authors: PARIS D PARKER TA TOWN T SUO ZM FANG CH HUMPHREY J CRAWFORD F MULLAN M
Citation: D. Paris et al., ROLE OF PEROXYNITRITE IN THE VASOACTIVE AND CYTOTOXIC EFFECTS OF ALZHEIMERS BETA-AMYLOID(1-40) PEPTIDE, Experimental neurology, 152(1), 1998, pp. 116-122
CHARACTERISTICS OF THE IN-VITRO VASOACTIVITY OF BETA-AMYLOID PEPTIDES
Authors: CRAWFORD F SUO ZM FANG CH MULLAN M
Citation: F. Crawford et al., CHARACTERISTICS OF THE IN-VITRO VASOACTIVITY OF BETA-AMYLOID PEPTIDES, Experimental neurology, 150(1), 1998, pp. 159-168
ALZHEIMERS BETA-AMYLOID PEPTIDES INDUCE INFLAMMATORY CASCADE IN HUMANVASCULAR CELLS - THE ROLES OF CYTOKINES AND CD40
Authors: SUO ZM TAN J PLACZEK A CRAWFORD F FANG CH MULLAN M
Citation: Zm. Suo et al., ALZHEIMERS BETA-AMYLOID PEPTIDES INDUCE INFLAMMATORY CASCADE IN HUMANVASCULAR CELLS - THE ROLES OF CYTOKINES AND CD40, Brain research, 807(1-2), 1998, pp. 110-117
NO ASSOCIATION BETWEEN THE VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR GENEAND LATE-ONSET ALZHEIMERS-DISEASE NOR INTERACTION WITH THE APOLIPOPROTEIN-E GENE IN POPULATION-BASED AND CLINIC SAMPLES
Authors: FALLIN D GAUNTLETT AC SCIBELLI P CAI XG DUARA R GOLD M CRAWFORD F MULLAN M
Citation: D. Fallin et al., NO ASSOCIATION BETWEEN THE VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR GENEAND LATE-ONSET ALZHEIMERS-DISEASE NOR INTERACTION WITH THE APOLIPOPROTEIN-E GENE IN POPULATION-BASED AND CLINIC SAMPLES, Genetic epidemiology, 14(3), 1997, pp. 299-305
NO ASSOCIATION BETWEEN THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) GENE AND LATE-ONSET ALZHEIMERS-DISEASE IN A COMMUNITY-BASED SAMPLE
Authors: FALLIN D KUNDTZ A TOWN T GAUNTLETT AC DUARA R BARKER W CRAWFORD F MULLAN M
Citation: D. Fallin et al., NO ASSOCIATION BETWEEN THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) GENE AND LATE-ONSET ALZHEIMERS-DISEASE IN A COMMUNITY-BASED SAMPLE, Neuroscience letters, 233(2-3), 1997, pp. 145-147
APOE IS LINKED TO ALZHEIMERS-DISEASE IN A LARGE PEDIGREE
Authors: CAI XG FALLIN D STANTON J SCIBELLI P DUARA R CRAWFORD F MULLAN M
Citation: Xg. Cai et al., APOE IS LINKED TO ALZHEIMERS-DISEASE IN A LARGE PEDIGREE, American journal of medical genetics, 74(4), 1997, pp. 365-369
LACK OF ASSOCIATION BETWEEN THE APOLIPOPROTEIN-E EPSILON-4 ALLELE (APOE EPSILON-4) AND CHRONIC-SCHIZOPHRENIA
Authors: TOWN T FALLIN D CRAWFORD F WALSH S SOLOMON R MULLAN M
Citation: T. Town et al., LACK OF ASSOCIATION BETWEEN THE APOLIPOPROTEIN-E EPSILON-4 ALLELE (APOE EPSILON-4) AND CHRONIC-SCHIZOPHRENIA, American journal of medical genetics, 74(4), 1997, pp. 451-452
NO INTERACTION BETWEEN THE APOE AND THE ALPHA-1-ANTICHYMOTRYPSIN GENES ON RISK FOR ALZHEIMERS-DISEASE
Authors: FALLIN D READING S SCHINKA J HOYNE J SCIBELLI P GOLD M CRAWFORD F MULLAN M
Citation: D. Fallin et al., NO INTERACTION BETWEEN THE APOE AND THE ALPHA-1-ANTICHYMOTRYPSIN GENES ON RISK FOR ALZHEIMERS-DISEASE, American journal of medical genetics, 74(2), 1997, pp. 192-194
NO ASSOCIATION BETWEEN THE INTRONIC PRESENILIN-1 POLYMORPHISM AND ALZHEIMERS-DISEASE IN CLINIC AND POPULATION-BASED SAMPLES
Authors: CAI XG STANTON J FALLIN D HOYNE J DUARA R GOLD M SEVUSH S SCIBELLI P CRAWFORD F MULLAN M
Citation: Xg. Cai et al., NO ASSOCIATION BETWEEN THE INTRONIC PRESENILIN-1 POLYMORPHISM AND ALZHEIMERS-DISEASE IN CLINIC AND POPULATION-BASED SAMPLES, American journal of medical genetics, 74(2), 1997, pp. 202-203
APOE EPSILON-4 ALLELE FREQUENCY (F-EPSILON-4) AND SUBJECTIVE MEMORY DISORDER
Authors: BARKER WW BRAVO M GREENFIELD L AGUERO H HARWOOD D BUCHILLON D MULLAN M DUARA R
Citation: Ww. Barker et al., APOE EPSILON-4 ALLELE FREQUENCY (F-EPSILON-4) AND SUBJECTIVE MEMORY DISORDER, Neurology, 48(3), 1997, pp. 1097-1097
THE USE OF APOE EPSILON-4 ALLELE FREQUENCY (F-EPSILON-4) AS A BIOLOGICAL MARKER FOR DETERMINING THE CUT SCORES OF DEMENTIA SCREENING-TESTS IN EPIDEMIOLOGIC STUDIES
Authors: DUARA R BARKER W LOEWENSTEIN D GREENFIELD L BRAVO M BUCHILLON D HURWITZ D CRAWFORD F MULLAN M
Citation: R. Duara et al., THE USE OF APOE EPSILON-4 ALLELE FREQUENCY (F-EPSILON-4) AS A BIOLOGICAL MARKER FOR DETERMINING THE CUT SCORES OF DEMENTIA SCREENING-TESTS IN EPIDEMIOLOGIC STUDIES, Neurology, 48(3), 1997, pp. 5058-5058
SUPEROXIDE FREE-RADICAL AND INTRACELLULAR CALCIUM MEDIATE A-BETA(1-42) INDUCED ENDOTHELIAL TOXICITY
Authors: SUO ZM FANG CH CRAWFORD F MULLAN M
Citation: Zm. Suo et al., SUPEROXIDE FREE-RADICAL AND INTRACELLULAR CALCIUM MEDIATE A-BETA(1-42) INDUCED ENDOTHELIAL TOXICITY, Brain research, 762(1-2), 1997, pp. 144-152
NO ASSOCIATION BETWEEN THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) GENE AND LATE-ONSET ALZHEIMERS-DISEASE IN A COMMUNITY-BASED SAMPLE
Authors: FALLIN D KUNDTZ A TOWN T GAUNTLETT AC DUARA R BARKER W CRAWFORD F MULLAN M
Citation: D. Fallin et al., NO ASSOCIATION BETWEEN THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) GENE AND LATE-ONSET ALZHEIMERS-DISEASE IN A COMMUNITY-BASED SAMPLE, American journal of human genetics, 61(4), 1997, pp. 1143-1143
VASOACTIVITY OF THE ALZHEIMER A-BETA PEPTIDES AND FIBRILLOGENIC POTENTIAL
Authors: CRAWFORD F SUO ZM FANG CH FRANGIONE B MULLAN M
Citation: F. Crawford et al., VASOACTIVITY OF THE ALZHEIMER A-BETA PEPTIDES AND FIBRILLOGENIC POTENTIAL, American journal of human genetics, 61(4), 1997, pp. 1929-1929
APO-E GENOTYPE AND PSYCHIATRIC FEATURES IN ALZHEIMERS-DISEASE
Authors: CANTILLON M BARKER W HARWOOD D MULLAN M DUARA R
Citation: M. Cantillon et al., APO-E GENOTYPE AND PSYCHIATRIC FEATURES IN ALZHEIMERS-DISEASE, The American journal of geriatric psychiatry, 4(4), 1996, pp. 357-358
RISK-FACTORS FOR ALZHEIMERS-DISEASE IN WOMEN
Authors: DUARA R BARKER W HARWOOD D SCHEUER B FLORENCE R HYSLOP PS MULLAN M
Citation: R. Duara et al., RISK-FACTORS FOR ALZHEIMERS-DISEASE IN WOMEN, Annals of neurology, 40(3), 1996, pp. 42-42
DOPAMINE DRD2 CYS311 IS NOT ASSOCIATED WITH CHRONIC-SCHIZOPHRENIA/
Authors: CRAWFORD F HOYNE J CAI XG OSBORNE A POSTON D ZAGLUL J DAJANI N WALSH S BRADLEY R SOLOMON R MULLAN M
Citation: F. Crawford et al., DOPAMINE DRD2 CYS311 IS NOT ASSOCIATED WITH CHRONIC-SCHIZOPHRENIA/, American journal of medical genetics, 67(5), 1996, pp. 483-484
APOLIPOPROTEIN-E GENOTYPING IN ALZHEIMERS-DISEASE
Authors: RELKIN NR TANZI R BREITNER J FARRER L GANDY S HAINES J HYMAN B MULLAN M POIRER J STRITTMATTER W FOLSTEIN M FARLOW M MAYEUX R PETERSEN R ROSES A SCHENK D SMALL G VANGOOL W COOKDEEGAN R FLECK L KAPP M KARLINSKY H PERICAKVANCE M POST S WOLPERT C BERG L BLASS J FLETCHER J HEGELE R KHACHATURIAN Z SELKOE D THAL L WHITEHOUSE P KWON YG
Citation: Nr. Relkin et al., APOLIPOPROTEIN-E GENOTYPING IN ALZHEIMERS-DISEASE, Lancet, 347(9008), 1996, pp. 1091-1095
Risultati: 1-25 | 26-50